OR WAIT null SECS
July 03, 2022
Demand spurs innovations in syringes and syringe fill/finish operations.
June 29, 2022
MilliporeSigma and Lotte Group will collaborate on facility design and workforce training for a new biologics business unit in the US.
June 10, 2022
Astellas Pharma has opened its new gene therapy manufacturing facility in Sanford, NC, which will support clinical- and commercial-scale manufacturing of AAV vectors for gene therapies.
The expansion at Seqirus’ Holly Springs, N.C., manufacturing facility will support the formulation and fill/finish of influenza vaccines.
May 26, 2022
Lonza and Israel Biotech Fund form a two-year agreement to support accelerated development and manufacture of biologics and small molecules.
AGC Biologics is investing in viral vector suspension technology at its new Longmont, Colo., facility.
May 16, 2022
Flexible and efficient methods are needed for biopharmaceutical manufacturing.
The struggle to implement continuous biomanufacturing at GMP level is slowly advancing.
May 03, 2022
Resolving operational bottlenecks makes mAb manufacturing more efficient.
April 06, 2022
Standardization is needed in CAR-T cell therapy development due to its inherent complexity.